Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome b-c1 complex subunit 6, mitochondrial (UQCRH) is a nuclear-encoded subunit of the mitochondrial respiratory chain Complex III (ubiquinol:cytochrome c oxidoreductase), located in the inner mitochondrial membrane. UQCRH, also known as the mitochondrial hinge protein, regulates the electron transfer between cytochrome c1 and cytochrome c, contributing to maintenance of mitochondrial membrane potential and efficient oxidative phosphorylation. Although not strictly essential for Complex III assembly or basic function, UQCRH modulates electron flow efficiency; its loss in renal cell carcinoma is associated with DNA hypermethylation, mitochondrial dysfunction, a metabolic shift to glycolysis (the Warburg effect), impaired apoptosis, and worse clinical outcomes. UQCRH deficiency also underlies rare forms of mitochondrial complex III deficiency[1][2][3][6].
Decitabine acts as a DNA methyltransferase inhibitor, reversing the hypermethylation and restoring UQCRH expression in affected tumors[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b-c1 complex subunit 6, mitochondrial (UQCRH).